Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00253890 · ClinicalTrials.gov registry record · Phase 3
Insomnia and Drug Relapse Risk
A Phase 3 study, sponsored by Butler Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 137
- Enrollment target
NCT00253890 is a Phase 3 study that has completed, run by Butler Hospital. The registered enrollment target is 137 participants.
The verdict
NCT00253890, a Phase 3 study, has completed, sponsored by Butler Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 137 participants
- Enrollment target
Study Summary
The purposes of this study are: 1. to evaluate the relationship between subjective complaints of sleep and objective measures of sleep quality, as measured through polysomnography, and 2. to evaluate the efficacy of trazodone, as compared to placebo, in individuals early in methadone maintenance.
Interventions
- DRUG Placebo
- DRUG Trazodone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 137 participants |
| Start Date | 2005-10 |
| Est. Completion | 2010-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00253890
The ClinicalTrials.gov registry entry for NCT00253890 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 137 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Butler Hospital, which has 103 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00253890 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00253890 about?
NCT00253890 is a clinical study titled "Insomnia and Drug Relapse Risk". The purposes of this study are: 1. to evaluate the relationship between subjective complaints of sleep and objective measures of sleep quality, as measured through polysomnography, and 2. to evaluate the efficacy of trazodone, as compared to placebo, in individuals early in methadone maintenance.
What is the current status of trial NCT00253890?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 137 participants. The study started on 2005-10. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00253890?
The interventions under investigation include: Placebo (DRUG), Trazodone (DRUG).
Who is sponsoring clinical trial NCT00253890?
This trial is sponsored by Butler Hospital, which has 103 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.